Moneycontrol PRO
UPCOMING EVENT:Special webinar on Highlights of global investing in 2021 and what lies ahead' at 2 pm on 21st January, 2022. Register Now!

Marksans Pharma Consolidated September 2021 Net Sales at Rs 361.20 crore, up 1.33% Y-o-Y

November 10, 2021 / 04:54 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Consolidated quarterly numbers for Marksans Pharma are:

Net Sales at Rs 361.20 crore in September 2021 up 1.33% from Rs. 356.47 crore in September 2020.

Quarterly Net Profit at Rs. 46.29 crore in September 2021 down 8.76% from Rs. 50.73 crore in September 2020.

EBITDA stands at Rs. 68.67 crore in September 2021 down 20.91% from Rs. 86.82 crore in September 2020.

Marksans Pharma EPS has decreased to Rs. 1.11 in September 2021 from Rs. 1.21 in September 2020.

Close

Marksans Pharma shares closed at 67.35 on November 09, 2021 (NSE) and has given -13.49% returns over the last 6 months and 30.65% over the last 12 months.

Marksans Pharma
Consolidated Quarterly Resultsin Rs. Cr.
Sep'21Jun'21Sep'20
Net Sales/Income from operations361.20348.96356.47
Other Operating Income------
Total Income From Operations361.20348.96356.47
EXPENDITURE
Consumption of Raw Materials170.21113.34117.64
Purchase of Traded Goods32.946.3352.72
Increase/Decrease in Stocks-27.7742.63-6.67
Power & Fuel------
Employees Cost54.7949.0543.88
Depreciation7.397.4718.99
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses70.9360.2865.75
P/L Before Other Inc., Int., Excpt. Items & Tax52.7169.8764.16
Other Income8.575.883.67
P/L Before Int., Excpt. Items & Tax61.2875.7567.83
Interest1.500.971.93
P/L Before Exceptional Items & Tax59.7874.7865.90
Exceptional Items------
P/L Before Tax59.7874.7865.90
Tax13.4912.1815.16
P/L After Tax from Ordinary Activities46.2962.6050.73
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period46.2962.6050.73
Minority Interest------
Share Of P/L Of Associates------
Net P/L After M.I & Associates46.2962.6050.73
Equity Share Capital40.9340.9340.93
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS1.111.511.21
Diluted EPS1.111.511.21
EPS After Extra Ordinary
Basic EPS1.111.511.21
Diluted EPS1.111.511.21
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited

first published: Nov 10, 2021 04:44 pm

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark